INBX Inhibrx Biosciences, Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $1.2B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $5.9M | $0 |
| 2024-Q3 | $3.8M | $0 |
| 2024-Q4 | $861.9K | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $11.3M |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $5.5M | $279.0K |
| 2026-Q4 | $840.4K | $0 |
Bought$16.9M31 buy days
Sold$11.6M6 sell days
Net insider flow+$5.4Mnet buying · 5 years
Latest trade2026-10-14Lappe Mark
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-10-14 | Buy | Lappe Mark | CEO | 9,940 | $84.55 | $840.4K | 5 |
| 2026-09-28 | Buy | Lappe Mark | CEO | 4,500 | $100.76 | $453.4K | 2 |
| 2026-09-25 | Buy | Lappe Mark | CEO | 5,500 | $99.16 | $545.4K | 2 |
| 2026-09-23 | Buy | Kayyem Jon Faiz | Director | 5,000 | $100.00 | $500.0K | 1 |
| 2026-09-16 | Buy | Kayyem Jon Faiz | Director | 5,000 | $100.00 | $500.0K | 1 |
| 2026-09-15 | Sell | MANHARD KIMBERLY | Director | 500 | $105.05 | $52.5K | 1 |
| 2026-09-14 | Sell | MANHARD KIMBERLY | Director | 500 | $110.26 | $55.1K | 1 |
| 2026-09-11 | Sell | MANHARD KIMBERLY | Director | 500 | $111.78 | $55.9K | 1 |
| 2026-09-09 | Sell | MANHARD KIMBERLY | Director | 500 | $115.80 | $57.9K | 1 |
| 2026-09-08 | Buy | Lappe Mark | CEO | 25,000 | $105.82 | $2.6M | 6 |
| 2026-09-08 | Buy | Kayyem Jon Faiz | Director | 5,000 | $113.52 | $567.6K | 1 |
| 2026-09-08 | Buy | FORSYTH DOUGLAS | Director | 2,500 | $114.65 | $286.6K | 1 |
| 2026-09-08 | Sell | MANHARD KIMBERLY | Director | 500 | $115.14 | $57.6K | 1 |
| 2025-10-07 | Sell | VIKING GLOBAL INVESTORS LP | 10% owner | 350,000 | $32.25 | $11.3M | 3 |
| 2024-11-20 | Buy | Kayyem Jon Faiz | Director | 18,750 | $14.19 | $266.1K | 1 |
| 2024-11-19 | Buy | Kayyem Jon Faiz | Director | 34,843 | $14.23 | $495.8K | 1 |
| 2024-10-03 | Buy | Vuori Kristiina MD | Director | 6,667 | $15.00 | $100.0K | 1 |
| 2024-09-16 | Buy | Lappe Mark | CEO | 13,037 | $17.13 | $223.3K | 1 |
| 2024-09-12 | Buy | Lappe Mark | CEO | 26,963 | $15.05 | $405.8K | 1 |
| 2024-09-11 | Buy | Vuori Kristiina MD | Director | 6,457 | $15.07 | $97.3K | 1 |
| 2024-09-10 | Buy | Lappe Mark | CEO | 8,500 | $15.19 | $129.1K | 1 |
| 2024-09-10 | Buy | Vuori Kristiina MD | Director | 179 | $15.00 | $2.7K | 1 |
| 2024-09-09 | Buy | Lappe Mark | CEO | 9,500 | $15.21 | $144.5K | 1 |
| 2024-09-06 | Buy | Lappe Mark | CEO | 26,000 | $15.29 | $397.5K | 1 |
| 2024-09-03 | Buy | Lappe Mark | CEO | 20,000 | $15.81 | $316.3K | 2 |
| 2024-08-30 | Buy | Lappe Mark | CEO | 10,000 | $14.02 | $140.2K | 1 |
| 2024-08-29 | Buy | Lappe Mark | CEO | 10,000 | $14.03 | $140.3K | 1 |
| 2024-08-29 | Buy | Vuori Kristiina MD | Director | 7,140 | $14.00 | $100.0K | 1 |
| 2024-08-28 | Buy | MANHARD KIMBERLY | Director | 10,000 | $13.98 | $139.8K | 1 |
| 2024-08-23 | Buy | FORSYTH DOUGLAS | Director | 59,812 | $14.07 | $841.6K | 1 |
| 2024-08-22 | Buy | FORSYTH DOUGLAS | Director | 15,188 | $12.89 | $195.8K | 1 |
| 2024-08-21 | Buy | Lappe Mark | CEO | 12,945 | $12.93 | $167.4K | 1 |
| 2024-08-20 | Buy | Lappe Mark | CEO | 27,055 | $12.97 | $350.9K | 1 |
| 2024-06-05 | Buy | Kayyem Jon Faiz | Director | 57,549 | $17.32 | $997.0K | 2 |
| 2024-06-04 | Buy | Kayyem Jon Faiz | Director | 89,063 | $17.65 | $1.6M | 2 |
| 2024-06-03 | Buy | Kayyem Jon Faiz | Director | 127,530 | $17.43 | $2.2M | 2 |
| 2024-05-31 | Buy | Kayyem Jon Faiz | Director | 70,193 | $16.14 | $1.1M | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 10% owner | $0 | $11.3M | 2025-10-07 |
| Kayyem Jon Faiz | Director | $8.3M | $0 | 2026-09-23 |
| Lappe Mark | CEO | $6.9M | $0 | 2026-10-14 |
| FORSYTH DOUGLAS | Director | $1.3M | $0 | 2026-09-08 |
| MANHARD KIMBERLY | Director | $139.8K | $279.0K | 2026-09-15 |
| Vuori Kristiina MD | Director | $300.0K | $0 | 2024-10-03 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2026-09-08 → 2026-10-14 | 3 | $6.3M | 69 | -15.8% (-21.0% raw) | – | – | active |
| 2024-08-20 → 2024-10-03 | 4 | $3.9M | 67 | +5.0% (+5.1% raw) | -8.3% (+2.9% raw) | -3.8% (-9.1% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.